Core Alternative Capital Amgen Inc Transaction History

Core Alternative Capital

$448 Million
Q4 2024

A detailed history of Core Alternative Capital transactions in Amgen Inc stock. As of the latest transaction made, Core Alternative Capital holds 9,138 shares of AMGN stock, worth $2.66 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

9,138

Previous 10,934 16.43%

Holding current value

$2.66 Million

Previous $3.52 Million 32.42%

% of portfolio

0.53%

Previous 0.71%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$258.78 - $328.31 $464,768 - $589,644	-1,796 Reduced 16.43%	9,138 $2.38 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $781,184 - $851,884	-2,525 Reduced 18.76%	10,934 $3.52 Million
Q2 2024 Aug 16, 2024	SELL	$262.75 - $319.31 $1.29 Million - $1.57 Million	-4,919 Reduced 26.77%	13,459 $4.21 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $1.8 Million - $2.18 Million	-6,709 Reduced 26.74%	18,378 $5.23 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $2.75 Million - $3.1 Million	-10,745 Reduced 29.99%	25,087 $7.23 Million
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $932,760 - $1.16 Million	-4,266 Reduced 10.64%	35,832 $9.63 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $1.93 Million - $2.28 Million	-8,993 Reduced 18.32%	40,098 $8.9 Million
Q1 2023 Apr 18, 2023	SELL	$225.79 - $275.2 $1.16 Million - $1.41 Million	-5,123 Reduced 9.45%	49,091 $11.9 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $1.37 Million - $1.74 Million	5,973 Added 12.38%	54,214 $14.2 Million
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $4.27 Million - $4.81 Million	19,003 Added 64.99%	48,241 $10.9 Million
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $714,739 - $795,380	3,098 Added 11.85%	29,238 $7.11 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $2.22 Million - $2.46 Million	-10,147 Reduced 27.96%	26,140 $6.32 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $287,779 - $329,337	1,447 Added 4.15%	36,287 $7.91 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $839,315 - $983,359	3,954 Added 12.8%	34,840 $7.41 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $1.22 Million - $1.35 Million	5,222 Added 20.35%	30,886 $7.53 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $238,997 - $278,512	1,077 Added 4.38%	25,664 $6.39 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $619,279 - $737,451	2,862 Added 13.17%	24,587 $5.65 Million
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $693,625 - $771,368	-2,956 Reduced 11.98%	21,725 $5.52 Million
Q2 2020 Jul 13, 2020	BUY	$197.81 - $242.74 $234,207 - $287,404	1,184 Added 5.04%	24,681 $5.82 Million
Q1 2020 Jun 09, 2020	BUY	$182.24 - $241.7 $2.28 Million - $3.02 Million	12,491 Added 113.49%	23,497 $4.76 Million
Q4 2019 Jun 05, 2020	BUY	$189.21 - $243.2 $2.08 Million - $2.68 Million	11,006 New	11,006 $2.65 Million

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.

Account

Core Alternative Capital Amgen Inc Transaction History